Athira Pharma, Inc. (ATHA) DCF Valuation

Athira Pharma, Inc. (ATHA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Athira Pharma, Inc. (ATHA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Athira Pharma, Inc.? Our ATHA DCF Calculator integrates up-to-date data and extensive customization features, enabling you to refine your forecasts and enhance your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.8 -19.0 -54.4 -94.6 -116.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 2.0 .5 1.0 1.0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.8 -21.0 -54.9 -95.6 -117.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.1 184.7 253.8 200.3 147.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 1.3 2.3 1.2 1.6
Account Receivables, % 100 100 100 100 100
Inventories .0 -1.3 -2.3 -1.2 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .4 1.2 .6 2.5 .1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -2.3 -1.6 -1.1 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.4 -19.6 -54.4 -87.3 -117.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.0 -19.2 -56.1 -85.4 -121.0 1.5 .0 .0 .0 .0
WACC, % 16.86 16.87 16.89 16.86 16.89 16.87 16.87 16.87 16.87 16.87
PV UFCF
SUM PV UFCF 1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 1
Net Debt -89
Equity Value 90
Diluted Shares Outstanding, MM 38
Equity Value Per Share 2.37

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ATHA financials.
  • Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Athira Pharma’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, accompanied by step-by-step instructions.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical performance and future forecasts for Athira Pharma, Inc. (ATHA).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries that clearly present your valuation findings.
  • Suitable for All Levels: A straightforward, user-centric design tailored for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Get instant access to the Excel-based ATHA DCF Calculator.
  2. Input Your Assumptions: Adjust yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically updates Athira Pharma’s intrinsic value.
  4. Test Scenarios: Simulate different assumptions to evaluate potential valuation changes.
  5. Analyze and Decide: Use the results to guide your investment or financial analysis.

Why Choose This Calculator for Athira Pharma, Inc. (ATHA)?

  • Accuracy: Utilizes real Athira Pharma financials to ensure data precision.
  • Flexibility: Crafted for users to easily test and modify their inputs.
  • Time-Saving: Eliminate the need to build a DCF model from the ground up.
  • Professional-Grade: Designed with CFO-level accuracy and user experience in mind.
  • User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Athira Pharma, Inc. (ATHA) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Athira Pharma, Inc. (ATHA).
  • Consultants: Deliver professional valuation insights on Athira Pharma, Inc. (ATHA) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Athira Pharma, Inc. (ATHA) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Athira Pharma, Inc. (ATHA).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Athira Pharma historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Athira Pharma, Inc. (ATHA).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.